The combination of adagrasib and cetuximab may show clinical activity and promising survival outcomes in patients with metastatic, heavily pretreated, KRAS G12C–mutated colorectal cancer.
Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.
A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
In his ASCRS 2025 presentation titled "AI Scribing and Telephone Management," Robert T. Chang, MD, shared his insights about how artificial intelligence has impacted his practice and how it can help other practices to be more efficient.
A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.